Here's Gilead Sciences' Great COVID-19 Opportunity That You'll Really Want to Watch

Here's Gilead Sciences' Great COVID-19 Opportunity That You'll Really Want to Watch

Gilead's remdesivir won FDA Emergency Use Authorization (EUA) and received conditional approval in Europe as a treatment for the novel coronavirus disease. Remdesivir appears to be effective in treating hospitalized patients with COVID-19. Thus far, Gilead's primary focus has been on an intravenous form of remdesivir.